Top 5 Breakthrough Pharmaceutical Drugs of the Decade

Page 5 of 5
  1. Mounjaro

  2. Peak Sales Estimate at the Time of Approval (USD Billion): 25

    Disease: Type 2 Diabetes

    Company: Eli Lilly

    Mounjaro sales surged 72.3% to $979.7 million in Q2 2023, beating analyst estimates of $743 million. Sales swelled more than 70% since Q1 and most of these sales came from the US. Eli Lilly said significant demand is leading to delays in filling orders.

    The high demand shows patients switched from Lilly’s savings program to commercial insurance plans with higher reimbursement rates.

    Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 20 Most Commonly Used Recreational Drugs in America and the Top 20 Countries With Highest Drug Consumption.

Page 5 of 5